Standard versus rapid initiation of anti-hypertensive therapy

ISRCTN ISRCTN16286916
DOI https://doi.org/10.1186/ISRCTN16286916
Secondary identifying numbers N0237101856
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
16/09/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Shirley Hulme
Scientific

Diabetes Centre
Whiston Hospital
Prescot
L35 5DR
United Kingdom

Phone +44 (0)151 426 1600

Study information

Study designRandomised controlled trial, open design
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesThe aim of the study is to evaluate the impact on blood pressure control, patient satisfaction and well being and adherence to medication of conventional gradual titration of anti-hypertensive treatment versus rapid introduction and dose escalation of four anti-hypertensive agents in subjects with diabetic nephropathy.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCardiovascular: Hypertension
InterventionStandard versus rapid initiation of anti-hypertensive therapy
Intervention typeOther
Primary outcome measure1. Patient adherence to treatment
2. Blood pressure
3. Proteinuria
4. Adverse events
5. Treatment satisfaction
Secondary outcome measuresNot provided at time of registration
Overall study start date01/11/2001
Completion date01/04/2004

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants24
Key inclusion criteria24 subjects recruited from new patients entering the nephropathy clinic
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/11/2001
Date of final enrolment01/04/2004

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Diabetes Centre
Prescot
L35 5DR
United Kingdom

Sponsor information

Department of Health (UK)
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Government

St Helens and Knowsley Hospitals NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan